1,526
Views
95
CrossRef citations to date
0
Altmetric
ARTICLES

Effect of Buprenorphine Dose on Treatment Outcome

, , &
Pages 8-18 | Published online: 22 Feb 2012

REFERENCES

  • Cowan , A . 2007 . Buprenorphine: the basic pharmacology revisited . J Addict Med , 1 ( 2 ) : 68 – 72 .
  • Gerra , G , Fantoma , A and Zaimovic , A . 2006 . Naltrexone and buprenorphine combination in the treatment of opioid dependence . J Psychopharmacol , 20 ( 6 ) : 806 – 14 .
  • Jones , H J , Kaltenbach , K and Heil , H, et al. 2010 . Neonatal abstinence syndrome after methadone or buprenorphine exposure . N Engl J Med , 363 : 2320 – 31 .
  • Amass , L , Ling , W and Freese , TE, et al. 2004 . Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience . Am J Addict , 13 ( Suppl 1 ) : S42 – 66 .
  • Amass , L , Kamien , J B and Mikulich , S K . 2000 . Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet . Drug Alcohol Depend , 58 : 143 – 52 .
  • Caldiero , R , Parran , T Jr , Adelman , C and Piche , B . 2006 . Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved? . Am J Addict , 15 : 1 – 7 .
  • Johnson , R E , Eissenberg , T and Stitzer , MI, et al. 1995 . A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence . Drug Alcohol Depend , 40 : 17 – 25 .
  • White , J , Bell , J and Saunders , J, et al. 2009 . Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence . Drug Alcohol Depend , 103 : 37 – 43 .
  • Eder , H , Fischer , G , Gombas , W , Jagsch , R , Stuhlinger , G and Kasper , S . 1998 . Comparison of buprenorphine and methadone maintenance in opiate addicts . Eur Addict Res , 4 ( Suppl 1 ) : 3 – 7 .
  • Greenwald , M , Johanson , C and Schuster , C . 1999 . Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance . Drug Alcohol Depend , 56 : 191 – 203 .
  • Ling , W , Wesson , D R , Charuvastra , C and Klett , C J . 1996 . A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence . Arch Gen Psychiatry , 53 ( 5 ) : 401 – 7 .
  • Mattick , R P , Ali , R , White , J M , O’Brien , S , Wolk , S and Danz , C . 2003 . Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients . Addiction , 98 ( 4 ) : 441 – 52 .
  • Comer , S , Collins , E and Fischman . 2001 . Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans . Psychopharmacology , 154 : 28 – 37 .
  • Greenwald , M , Schuh , K , Hopper , J , Schuster , C and Johanson , C . 2002 . Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans . Psychopharmacology , 160 : 344 – 52 .
  • Kakko , J , Svanborg , K D , Kreek , M J and Heilig , M . 2003 . 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial . Lancet , 361 ( 9358 ) : 662 – 8 .
  • Ling , W , Charuvastra , C and Collins , JF, et al. 1998 . Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial . Addiction , 93 : 475 – 86 .
  • Fudala , P J , Bridge , T P and Herbert , S, et al. 2003 . Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone . N Engl J Med , 349 ( 10 ) : 949 – 58 .
  • Johnson , R E , Chutuape , M A , Strain , E C , Walsh , S L , Stitzer , M L and Bigelow , G E . 2000 . A comparison of levomethadyl acetate, buprenorphine, and METH for opioid dependence . N Engl J Med , 343 : 1290 – 7 .
  • Kakko , J , Grönbladh , L and Svanborg , KD, et al. 2007 . A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial . Am J Psychiatry , 164 ( 5 ) : 797 – 803 .
  • Benckiser , Reckitt . “ SUBOXONE treatment walk-through. http://suboxone.com/patients/about_suboxone_tablets.aspx ” . (accessed April 23, 2007)
  • Chakrabarti , A , Woody , G E , Griffin , M L , Subramaniam , G and Weiss , R D . 2010 . Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study . Drug Alcohol Depend , 107 ( 2–3 ) : 253 – 6 .
  • Dahan , A , Yassen , A and Romberg , R, et al. 2006 . Buprenorphine induces ceiling in respiratory depression but not in analgesia . Br J Anaesth , 96 : 627 – 62 .
  • Liguori , A , Morse , W H and Bergman , J . 1996 . Respiratory effects of opioid full and partial agonists in rhesus monkeys . J Pharmacol Exp Ther , 277 : 462 – 72 .
  • Walsh , S L , Preston , K L and Stitzer , ML, et al. 1994 . Clinical pharmacology of buprenorphine: ceiling effects at high doses . Clin Pharmacol Ther , 55 : 569 – 80 .
  • Häkkinen , M , Launiainen , T , Vuori , E and Ojanperä , I . 2011 . Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning . Eur J Clin Pharmacol , Sept 17 [Epub ahead of print]
  • Ferrant , O , Papin , F and Clin , B, et al. 2011 . Fatal poisoning due to snorting buprenorphine and alcohol consumption . Forensic Sci Int , 204 ( 1–3 ) : e8 – 11 .
  • Jadad , A R , Moore , R A and Carroll , D, et al. 1996 . Assessing the quality of reports of randomized clinical trials: is blinding necessary? . Control Clin Trials , 17 ( 1 ) : 1 – 12 . doi:10.1016/0197-2456(95)00134-4
  • Bell , J R , Butler , B , Lawrance , A , Batey , R and Salmelainen , P . 2009 . Comparing overdose mortality associated with methadone and buprenorphine treatment . Drug Alcohol Depend , 104 ( 1–2 ) : 73 – 7 .
  • Bell , J , Trinh , L , Butler , B , Randall , D and Rubin , G . 2009 . Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment . Addiction , 104 ( 7 ) : 1193 – 200 .
  • Altice , F L , Bruce , R D and Lucas , GM, et al. 2011 . BHIVES Collaborative. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study . J Acquir Immune Defic Syndr , 56 ( Suppl 1 ) : S22 – 32 .
  • Bilal , S , Menares , J , De La Selle , P , Toufik , A and Perdrieux , Y . 2003 . Effect of maintenance treatments on social life. A study with general practitioners [article in French] . Ann Med Interne (Paris) , 154 ( Spec No 2 ) : S6 – 14 .
  • Korthuis , P T , Fiellin , D A and Fu , R, et al . 2011 . BHIVES Collaborative. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine . J Acquir Immune Defic Syndr , 56 ( Suppl 1 ) : S83 – 90 .
  • Parran , T V , Adelman , C A and Merkin , B, et al. 2010 . Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy . Drug Alcohol Depend , 106 ( 1 ) : 56 – 60 .
  • Vergara-Rodriguez , P , Tozzi , M J and Botsko , M, et al . 2011 . BHIVES Collaborative. Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients . J Acquir Immune Defic Syndr , 56 ( Suppl 1 ) : S62 – 7 .
  • Korthuis , P T , Tozzi , M J and Nandi , V, et al . 2011 . BHIVES Collaborative. Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics . J Acquir Immune Defic Syndr , 56 ( Suppl 1 ) : S39 – 45 .
  • Auriacombe , M , Fatseas , M , Dubernet , J , Daulouede , J P and Tignol , J . 2004 . French field experience with buprenorphine . Am J Addict , 13 ( Suppl 1 ) : 17 – 28 .
  • Jenkinson , R A , Clark , N C , Fry , C L and Dobbin , M . 2005 . Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue? . Addiction , 100 : 197 – 205 .
  • Mattick , R P , Kimber , J , Breen , C and Davoli , M . 2008 . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence . Cochrane Database Syst Rev , : CD002207
  • Kosten , T R , Schottenfeld , R , Ziedonis , D and Falcioni , J . 1993 . Buprenorphine versus methadone maintenance for opioid dependence . J Nerv Ment Dis. , 181 : 358 – 64 .
  • Schottenfeld , R S , Pakes , J R , Oliveto , A , Ziedonis , D and Kosten , T R . 1997 . Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse . Arch Gen Psychiatry , 54 ( 8 ) : 713 – 20 .
  • Uehlinger , C , Deglon , J-J , Livoti , S , Petitjean , S , Waldvogel , D and Ladewig , D . 1998 . Comparison of buprenorphine and methadone in the treatment of opioid dependence: Swiss multicentre trial . Eur Addict Res , 4 : 13 – 8 .
  • Crits-Christoph , P , Siqueland , L and Blaine , J, et al. 1999 . Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study . Arch Gen Psychiatry , 56 : 493 – 502 .
  • Kosten , T , Oliveto , A and Feingold , A, et al. 2003 . Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients . Drug Alcohol Depend , 70 : 315 – 25 .
  • Schottenfeld , R S , Chawarski , M C and Pakes , JR, et al. 2005 . Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence . Am J Psychiatry , 162 : 340 – 9 .
  • Simpson , D D , Joe , G W and Fletcher , BW, et al. 1999 . A national evaluation of treatment outcomes for cocaine dependence . Arch Gen Psychiatry , 56 : 507 – 14 .
  • Springer , S A , Chen , S and Altice , F L . 2010 . Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment . J Urban Health , 87 ( 4 ) : 592 – 602 .
  • Sullivan , L E , Barry , D and Moore , BA, et al. 2006 . A trial of integrated buprenorphine/naloxone and HIV clinical care . Clin Infect Dis , 43 ( Suppl 4 ) : S184 – 90 .
  • Strain , E C , Stitzer , M L , Liebson , I A and Bigelow , G E . 1996 . Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index . J Clin Psychopharmacol , 16 ( 1 ) : 58 – 67 .
  • Woody , G E , Poole , S A and Subramaniam , G, et al. 2008 . Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial . JAMA , 300 ( 17 ) : 2003 – 11 .
  • Ahmadi , J. 2003 . Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients . J Subst Abuse Treat , 24 ( 3 ) : 217 – 20 .
  • Amass , L , Kamien , J B and Mikulich , S K . 2001 . Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans . Drug Alcohol Depend , 61 ( 2 ) : 173 – 81 .
  • Fiellin , D A , Pantalon , M V and Chawarski , MC, et al. 2006 . Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence . N Engl J Med , 355 ( 4 ) : 365 – 74 .
  • Lucas , G M , Chaudhry , A and Hsu , J, et al. 2010 . Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: a randomized trial . Ann Intern Med , 152 ( 11 ) : 704 – 11 .
  • Marsch , L A , Bickel , W K , Badger , G J and Jacobs , E A . 2005 . Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing . Drug Alcohol Depend , 77 ( 2 ) : 195 – 204 .
  • Montoya , I D , Gorelick , D A and Preston , KL, et al. 2004 . Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence . Clin Pharmacol Ther , 75 ( 1 ) : 34 – 48 .
  • Schottenfeld , R S , Pakes , J , O’Connor , P , Chawarski , M , Oliveto , A and Kosten , TR. 2000 . Thrice-weekly versus daily buprenorphine maintenance . Biol Psychiatr , 47 ( 12 ) : 1072 – 9 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.